Collaborate Disseminate
The U.S. Food and Drug Administration (FDA) has formally approved a booster dose of Pfizer’s COVID-19 vaccine for some populations in the United States. The approval allows a third Pfizer dose for those over the age of 65 and adults over 18 at high-ris… Continue reading FDA authorizes Pfizer COVID vaccine booster, for some groups
After receiving a vaccination shot, it’s likely that we’ll feel some side-effects. These can range from merely a sore arm to swollen lymph nodes and even a fever. Which side-effects …read more Continue reading Mechanisms Behind Vaccine Side-Effects: the Science that Causes That Sore Arm
An advisory panel to the US Food and Drug Administration (FDA) has overwhelmingly voted against recommending a broad COVID-19 vaccine booster program for all American adults at this time. Instead, the panel unanimously recommended boosters for those in… Continue reading FDA panel limits COVID booster recommendation to elderly, high-risk
Klebsiella pneumoniae is a nasty, opportunistic bacteria that can cause pneumonia. It’s a tough one to fight, but now researchers at Tulane University have developed an inhalable vaccine that, in mouse tests, can invoke a strong immune response against… Continue reading Inhalable vaccine fights antibiotic-resistant pneumonia in mice
A new article published in The Lancet is arguing against broadly administering COVID-19 vaccine booster shots at this point in time. The article is co-authored by two of the US Food and Drug Administration’s top vaccine advisors, both of whom recently … Continue reading Experts argue COVID-19 vaccine boosters should be delayed
New data from the US Centers for Disease Control and Prevention (CDC) is offering up-to-date insights into the effect of the Delta variant on vaccine effectiveness. The reports indicate unvaccinated people are still 10 times more likely to suffer hospi… Continue reading New CDC data shows COVID-19 vaccines still work well against Delta
A small but robust study from Yale University researchers is offering insights into the characteristics of severe COVID-19 infections in fully vaccinated individuals. Although these kinds of breakthrough infections are very rare, the research helps doc… Continue reading Yale study identifies those at risk of breakthrough COVID-19 infections
The director of the World Health Organization has said he is “appalled” at the extent of vaccine inequity spreading across the world. Global vaccine-sharing initiative COVAX has reported it is falling short of its distribution milestones as high and up… Continue reading WHO director “appalled” at inequity of COVID-19 vaccine distribution
A comprehensive new study, published in the journal Nature, is describing how the Delta variant of SARS-CoV-2 has so rapidly become dominant all over the world. The research offers thorough evidence Delta’s effective spread is through a combination of … Continue reading International study reveals how Delta came to dominate the pandemic
Scientists at Oxford have demonstrated a powerful pairing – a cancer vaccine and immunotherapy. In tests in mice, the vaccine boosted levels of tumor-hunting immune cells, while the immunotherapy made them more effective killers. Human trials are due t… Continue reading Oxford’s cancer vaccine/immunotherapy combo to head for human trials